GSK3B and diabetic kidney disease: Elevated serum lysophosphatidic acid (LPA) in DKD binds to LPA receptors on mesangial cells (90), activating glycogen synthase kinase 3 beta (GSK3β) and promoting nuclear translocation of SREBP1.